homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Dermatology
Urticaria, Vasculitis & Connective Tissue Disease

profile subject selected for My F1000 Medicine

Browse > Dermatology > Urticaria, Vasculitis & Connective Tissue Disease
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals)
/ Most viewed
(from specialty journals)
/ Hidden jewels
Page 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0

Confirmation
Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A, Abou-Raya S, Helmii M
J Rheumatol 2008 Sep 35(9):1801-8 [abstract on PubMed] [related articles] [order article]
Selected by | Margitta Worm with Claudia Rasche
Evaluated 1 Dec 2008

Recommended
F1000 Factor 3.0

New Finding
Acute hemorrhagic edema of young children (cockade purpura and edema): a case series and systematic review.
Fiore E, Rizzi M, …, Bianchetti MG, Simonetti GD
J Am Acad Dermatol 2008 Oct 59(4):684-95 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Arnold Oranje
Evaluated 14 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.
Notley CA, Inglis JJ, …, McNamee KE, Williams RO
J Exp Med 2008 Oct 27 205(11):2491-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Carlo Chizzolini
Evaluated 30 Oct 2008

Recommended
F1000 Factor 3.0

Hypothesis
New Finding
Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.
Dreyfus DH
Ann Allergy Asthma Immunol 2008 Jun 100(6):624-5 [abstract on PubMed] [related articles] [order article]
Selected by | Riccardo Asero
Evaluated 21 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
Bone marrow endothelial progenitors are defective in systemic sclerosis.
Del Papa N, Quirici N, …, Cortelezzi A, Lambertenghi-Deliliers G
Arthritis Rheum 2006 Aug 54(8):2605-15 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Jörg Distler with Christian Beyer
Evaluated 8 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
Lymphocytic thrombophilic arteritis: a newly described medium-sized vessel arteritis of the skin.
Lee JS, Kossard S, McGrath MA
Arch Dermatol 2008 Sep 144(9):1175-82 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | J Andrew Carlson
Evaluated 7 Oct 2008

Recommended
F1000 Factor 3.0

New Finding
IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.
Thibault DL, Chu AD, …, Tibshirani R, Utz PJ
J Clin Invest 2008 Apr 118(4):1417-26 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Ann Reed with Vaidehi R Chowdhary
Evaluated 3 Oct 2008

Recommended
F1000 Factor 3.0

New Finding
Increasing hospitalizations due to angioedema in the United States.
Lin RY, Shah SN
Ann Allergy Asthma Immunol 2008 Aug 101(2):185-92 [abstract on PubMed] [related articles] [order article]
Selected by | Marcus Maurer with Elena Angelica Ardelean
Evaluated 1 Oct 2008

Must Read
F1000 Factor 6.0

Hypothesis
Update on chronic urticaria: focusing on mechanisms.
M¿ynek A, Maurer M, Zalewska A
Curr Opin Allergy Clin Immunol 2008 Oct 8(5):433-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Riccardo Asero
Evaluated 12 Sep 2008

Must Read
F1000 Factor 6.0

New Finding
A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients.
Tosoni C, Lodi-Rizzini F, …, Sinico RA, Calzavara-Pinton P
Clin Exp Dermatol 2008 Aug 2 [abstract on PubMed] [related articles] [full text]
Selected by | Alexander Marsland
Evaluated 5 Sep 2008


top of pagePage 1 of 4. Select Page: 1 2 3 4 >>
Display 10 / 20 / 50 papers per page


© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info